197 related articles for article (PubMed ID: 27470937)
21. Stage-specific incidence of breast cancer before the beginning of organized screening programs in Italy.
Buiatti E; Barchielli A; Bartolacci S; Bucchi L; De LV; Federico M; Ferretti S; Paci E; Vettorazzi M; Zanetti R;
Cancer Causes Control; 2002 Feb; 13(1):65-71. PubMed ID: 11899119
[TBL] [Abstract][Full Text] [Related]
22. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.
Foca F; Mancini S; Bucchi L; Puliti D; Zappa M; Naldoni C; Falcini F; Gambino ML; Piffer S; Sanoja Gonzalez ME; Stracci F; Zorzi M; Paci E;
Cancer; 2013 Jun; 119(11):2022-8. PubMed ID: 23504860
[TBL] [Abstract][Full Text] [Related]
23. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
[TBL] [Abstract][Full Text] [Related]
24. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
25. Comparison of female breast cancer between Russia and Germany: A population-based study on time trends and stage at diagnosis.
Mahanani MR; Valkov M; Agaeva A; Kaucher S; Pikalova LV; Grishchenko MY; Zhuikova LD; Jaehn P; Winkler V
Cancer Epidemiol; 2022 Oct; 80():102214. PubMed ID: 35841762
[TBL] [Abstract][Full Text] [Related]
26. Impact of breast cancer screening in a population with high spontaneous coverage with mammography.
Capodaglio G; Zorzi M; Tognazzo S; Greco A; Michieletto F; Fedato C; Montaguti A; Turrin A; Ferro A; Cinquetti S; Russo F; Corti MC; Rugge M; Fedeli U
Tumori; 2018 Aug; 104(4):258-265. PubMed ID: 30079815
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival.
Kuklinski D; Blum M; Subelack J; Geissler A; Eichenberger A; Morant R
Breast Cancer Res; 2024 May; 26(1):84. PubMed ID: 38802897
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the impact of the mammography screening program on breast cancer mortality: feasibility study on linking several data sources in North Rhine-Westphalia].
Fuhs A; Bartholomäus S; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):60-7. PubMed ID: 24357174
[TBL] [Abstract][Full Text] [Related]
29. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
30. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
Hofvind S; Skaane P
Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
[TBL] [Abstract][Full Text] [Related]
31. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
32. German mammography screening program: program sensitivity between 2010 and 2016 estimated based on German health claims data.
Heinze F; Czwikla J; Heinig M; Langner I; Haug U
BMC Cancer; 2023 Sep; 23(1):852. PubMed ID: 37697304
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
[No Abstract] [Full Text] [Related]
34. Population-based mammography screening and breast cancer incidence in New South Wales, Australia.
Chiu C; Morrell S; Page A; Rickard M; Brassil A; Taylor R
Cancer Causes Control; 2006 Mar; 17(2):153-60. PubMed ID: 16425093
[TBL] [Abstract][Full Text] [Related]
35. Retrospective quantification of background incidence and stage distribution of breast cancer for the mammography screening pilot project in Wiesbaden, Germany.
Schott G; Reichel M; Junkermann H; Becker N
J Cancer Res Clin Oncol; 2008 Jan; 134(1):29-35. PubMed ID: 17602243
[TBL] [Abstract][Full Text] [Related]
36. Differences in Breast Cancer Characteristics by Mammography Screening Participation or Non-Participation.
Braun B; Khil L; Tio J; Krause-Bergmann B; Fuhs A; Heidinger O; Hense HW
Dtsch Arztebl Int; 2018 Aug; 115(31-32):520-527. PubMed ID: 30149831
[TBL] [Abstract][Full Text] [Related]
37. The natural history of invasive breast cancers detected by screening mammography.
Zahl PH; Maehlen J; Welch HG
Arch Intern Med; 2008 Nov; 168(21):2311-6. PubMed ID: 19029493
[TBL] [Abstract][Full Text] [Related]
38. Effect of organised mammography screening on stage-specific incidence in Norway: population study.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Br J Cancer; 2016 Mar; 114(5):590-6. PubMed ID: 26835975
[TBL] [Abstract][Full Text] [Related]
39. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
Welch HG; Prorok PC; O'Malley AJ; Kramer BS
N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
[TBL] [Abstract][Full Text] [Related]
40. Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects.
Herrmann C; Morant R; Walser E; Mousavi M; Thürlimann B
BMC Cancer; 2021 Mar; 21(1):229. PubMed ID: 33676446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
